A label on the front of the package says it is high in protein, has 3 grams of fiber and is "GLP-1 Friendly." "I'm interested in turning it around and seeing what their definition of 'GLP-1 Friendly' is," Wiseman says, flipping the box over and scouring the ingredients listed on the back, listed in order of prominence
For semaglutide, the STEP 1 trial published in the New England Journal of Medicine showed average weight loss of approximately 15% of body weight at 68 weeks
Intended use: Research use only
Out-of-Pocket Costs Drive Abandonment Especially in Obesity While payer restrictions and coverage gaps contribute to GLP-1 therapy abandonment, out-of-pocket (OOP) costs remain the most consistent and powerful predictor of non-adherence
doi:10.1038/embor.2009.216 Magyar, I., & Tth, T
Glucagon-like peptide-1 (GLP-1) inhibits advanced glycation end product (AGE)-induced up-regulation of VCAM-1 mRNA levels in endothelial cells by suppressing AGE receptor (RAGE) expression